Effects of the glucolipid synthase inhibitor, P4, on functional and phenotypic parameters of murine myeloma cells
1999
Effects of P4 on Myeloma Cells
publication
Evidence: moderate
Author Information
Author(s): Manning L S, Radin N S
Primary Institution: Research Centre, Royal Perth Hospital, Perth, Western Australia, Australia
Hypothesis
The glucolipid synthase inhibitor P4 affects functional and phenotypic parameters of murine myeloma cells.
Conclusion
P4 significantly reduces the growth and viability of myeloma cells and alters their phenotypic markers.
Supporting Evidence
- Cell recovery was reduced by over 85% after treatment with P4.
- Cytostatic and cytotoxic effects were observed, with metabolic activity and clonogenic potential significantly reduced.
- Viability of the cells decreased to 52% after treatment.
- A dose-dependent increase in apoptosis was noted, rising from 7% to 26%.
- P4 altered the expression of various phenotypic markers on the myeloma cells.
Takeaway
P4 is a substance that can make cancer cells grow less and die more, which could help treat multiple myeloma.
Methodology
The study involved incubating 5T33 murine myeloma cells with P4 and measuring various functional and phenotypic parameters.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website